Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Clinical trial NCT04459065 · RECRUITING
Trial details
- NCT number
- NCT04459065
- Sponsor
- University of Saskatchewan
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.